A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve Damage | MicrobiomeTrials← Back to trialsNCT07770685
A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve Damage
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-08-14Est. Completion: 2030-07-31
Enrollment target: 156 participants Locations- Ophthalmic Consultants of Boston and Boston Eye Surgery & Laser Center, Boston, Massachusetts, United States
Other microbiome trials you might be interested in
GlaucomaGlaucoma, Suspect
Goldmann Applanation Tonometry (GAT) is considered the clinical gold standard for eye pressure measurements and yet it i…
Durham, United StatesCompleted May 31, 2024
Glaucoma, Open-anglePrimary Open Angle Glaucoma (POAG)
The goal of this clinical trial is to learn whether a high-dose vitamin B3 supplement called nicotinamide can protect re…
Chicago, United StatesEst. completion Sep 30, 2029